JP2022505670A5 - - Google Patents
Info
- Publication number
- JP2022505670A5 JP2022505670A5 JP2021522086A JP2021522086A JP2022505670A5 JP 2022505670 A5 JP2022505670 A5 JP 2022505670A5 JP 2021522086 A JP2021522086 A JP 2021522086A JP 2021522086 A JP2021522086 A JP 2021522086A JP 2022505670 A5 JP2022505670 A5 JP 2022505670A5
- Authority
- JP
- Japan
- Prior art keywords
- crystalline salt
- salt
- xrpd
- pattern
- theta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024085295A JP2024109860A (ja) | 2018-11-02 | 2024-05-27 | 血漿カリクレイン阻害剤の結晶塩 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862754983P | 2018-11-02 | 2018-11-02 | |
| US62/754,983 | 2018-11-02 | ||
| PCT/US2019/059385 WO2020092898A1 (en) | 2018-11-02 | 2019-11-01 | Crystalline salts of a plasma kallikrein inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024085295A Division JP2024109860A (ja) | 2018-11-02 | 2024-05-27 | 血漿カリクレイン阻害剤の結晶塩 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022505670A JP2022505670A (ja) | 2022-01-14 |
| JP2022505670A5 true JP2022505670A5 (https=) | 2022-10-17 |
Family
ID=70457981
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522086A Pending JP2022505670A (ja) | 2018-11-02 | 2019-11-01 | 血漿カリクレイン阻害剤の結晶塩 |
| JP2024085295A Pending JP2024109860A (ja) | 2018-11-02 | 2024-05-27 | 血漿カリクレイン阻害剤の結晶塩 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024085295A Pending JP2024109860A (ja) | 2018-11-02 | 2024-05-27 | 血漿カリクレイン阻害剤の結晶塩 |
Country Status (22)
| Country | Link |
|---|---|
| US (11) | US10662160B1 (https=) |
| EP (1) | EP3873463A4 (https=) |
| JP (2) | JP2022505670A (https=) |
| KR (1) | KR102810837B1 (https=) |
| CN (1) | CN112969458A (https=) |
| AR (1) | AR116951A1 (https=) |
| AU (1) | AU2019374115B8 (https=) |
| BR (1) | BR112021008249A2 (https=) |
| CA (1) | CA3117123A1 (https=) |
| CL (1) | CL2021001094A1 (https=) |
| CO (1) | CO2021007172A2 (https=) |
| EA (1) | EA202191192A1 (https=) |
| IL (2) | IL322896A (https=) |
| MA (1) | MA54087A (https=) |
| MX (1) | MX2021004917A (https=) |
| PE (1) | PE20211280A1 (https=) |
| PH (1) | PH12021550883A1 (https=) |
| PY (1) | PY1991831A (https=) |
| SG (1) | SG11202103804TA (https=) |
| TW (1) | TW202031255A (https=) |
| UY (1) | UY38438A (https=) |
| WO (1) | WO2020092898A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102736869B1 (ko) | 2014-03-07 | 2024-12-02 | 바이오크리스트파마슈티컬즈,인코포레이티드 | 인간 혈장 칼리크레인 저해제 |
| UY38438A (es) | 2018-11-02 | 2020-05-29 | Biocryst Pharm Inc | Sales cristalinas de un inhibidor de calicreína plasmática |
| WO2021025969A1 (en) * | 2019-08-02 | 2021-02-11 | Teva Pharmaceuticals International Gmbh | Solid state forms of berotralstat |
| CN116375648A (zh) * | 2023-03-22 | 2023-07-04 | 苏州农平科技发展有限公司 | 贝罗司他中间体的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4559157A (en) * | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
| BRPI0519331A2 (pt) | 2004-12-15 | 2009-01-20 | Bristol Myers Squibb Co | formas cristalina de um inibidor de fator xa |
| CN101495468A (zh) * | 2006-07-31 | 2009-07-29 | 艾克提弗赛特制药股份有限公司 | 血浆激肽释放酶抑制剂 |
| WO2008016883A2 (en) | 2006-07-31 | 2008-02-07 | Activesite Pharmaceuticals, Inc. | Inhibitors of plasma kallikrein |
| RU2585683C2 (ru) * | 2010-05-19 | 2016-06-10 | Сандоз Аг | Очистка позаконазола и промежуточных продуктов для синтеза позаконазола |
| US9012464B2 (en) | 2010-11-25 | 2015-04-21 | Ratiopharm Gmbh | Salts and polymorphic forms of Afatinib |
| GB201212081D0 (en) * | 2012-07-06 | 2012-08-22 | Kalvista Pharmaceuticals Ltd | New polymorph |
| KR102736869B1 (ko) * | 2014-03-07 | 2024-12-02 | 바이오크리스트파마슈티컬즈,인코포레이티드 | 인간 혈장 칼리크레인 저해제 |
| DK4019022T3 (en) | 2015-10-01 | 2024-02-19 | Biocryst Pharm Inc | Human plasma kallikrein inhibitors |
| UY38438A (es) | 2018-11-02 | 2020-05-29 | Biocryst Pharm Inc | Sales cristalinas de un inhibidor de calicreína plasmática |
| CN114206839B (zh) | 2019-08-06 | 2025-03-07 | 拜奥克里斯特制药公司 | 血浆激肽释放酶抑制剂的生产规模合成 |
-
2019
- 2019-10-31 UY UY0001038438A patent/UY38438A/es not_active Application Discontinuation
- 2019-10-31 AR ARP190103187A patent/AR116951A1/es unknown
- 2019-11-01 IL IL322896A patent/IL322896A/en unknown
- 2019-11-01 EP EP19877809.4A patent/EP3873463A4/en active Pending
- 2019-11-01 CA CA3117123A patent/CA3117123A1/en active Pending
- 2019-11-01 PE PE2021000587A patent/PE20211280A1/es unknown
- 2019-11-01 PY PY201901991831A patent/PY1991831A/es unknown
- 2019-11-01 CN CN201980072995.3A patent/CN112969458A/zh active Pending
- 2019-11-01 US US16/671,649 patent/US10662160B1/en active Active
- 2019-11-01 MX MX2021004917A patent/MX2021004917A/es unknown
- 2019-11-01 MA MA054087A patent/MA54087A/fr unknown
- 2019-11-01 EA EA202191192A patent/EA202191192A1/ru unknown
- 2019-11-01 WO PCT/US2019/059385 patent/WO2020092898A1/en not_active Ceased
- 2019-11-01 KR KR1020217013734A patent/KR102810837B1/ko active Active
- 2019-11-01 BR BR112021008249-2A patent/BR112021008249A2/pt unknown
- 2019-11-01 TW TW108139655A patent/TW202031255A/zh unknown
- 2019-11-01 SG SG11202103804TA patent/SG11202103804TA/en unknown
- 2019-11-01 AU AU2019374115A patent/AU2019374115B8/en active Active
- 2019-11-01 JP JP2021522086A patent/JP2022505670A/ja active Pending
-
2020
- 2020-02-06 US US16/784,016 patent/US11117867B2/en active Active
-
2021
- 2021-04-20 IL IL282454A patent/IL282454A/en unknown
- 2021-04-21 PH PH12021550883A patent/PH12021550883A1/en unknown
- 2021-04-27 CL CL2021001094A patent/CL2021001094A1/es unknown
- 2021-05-31 CO CONC2021/0007172A patent/CO2021007172A2/es unknown
- 2021-09-02 US US17/465,181 patent/US11618733B2/en active Active
-
2023
- 2023-03-10 US US18/120,073 patent/US12344585B2/en active Active
-
2024
- 2024-05-27 JP JP2024085295A patent/JP2024109860A/ja active Pending
-
2025
- 2025-05-30 US US19/224,669 patent/US20250388545A1/en active Pending
- 2025-08-28 US US19/312,645 patent/US12545645B2/en active Active
- 2025-08-28 US US19/312,656 patent/US12552750B2/en active Active
- 2025-08-28 US US19/313,010 patent/US12590068B2/en active Active
- 2025-08-28 US US19/312,755 patent/US12545646B2/en active Active
- 2025-08-28 US US19/313,046 patent/US12590069B2/en active Active
- 2025-08-28 US US19/312,786 patent/US12545647B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022505670A5 (https=) | ||
| JP2021169499A5 (https=) | ||
| EA020473B1 (ru) | СПОСОБ ОЧИСТКИ 1-[2-(2,4-ДИМЕТИЛФЕНИЛСУЛЬФАНИЛ)ФЕНИЛ]ПИПЕРАЗИНА-HBr | |
| CN105646389A (zh) | 一种作为吲哚胺-2,3-双加氧酶抑制剂的氨基磺酸脂及其制备方法和用途 | |
| WO2011141933A2 (en) | Process for preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid and its pharmaceutically acceptable salts | |
| CN101676266A (zh) | 氘代的ω-二苯基脲及衍生物以及包含该化合物的药物组合物 | |
| CN105085360A (zh) | 一种高纯度维格列汀的制备方法 | |
| EP3100735B1 (en) | Crystalline fosaprepitant dicyclohexylamine salt and its preparation | |
| JP2021532107A (ja) | ジカチオン化合物及びその製造方法と使用 | |
| JP2025536416A5 (https=) | ||
| JP5341521B2 (ja) | タンパク質と結合パートナーとの相互作用を阻害するための化合物及び方法 | |
| JP2002520404A (ja) | 多環チアゾリジン−２−イリデンアミン、その調製方法および医薬としてのその使用 | |
| EP3755693A1 (en) | Agents and methods for treating dysproliferative diseases | |
| WO2025176185A1 (zh) | 一种braf抑制剂的制备方法 | |
| WO2014128094A1 (en) | Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide | |
| WO2017202357A1 (zh) | 一种三氟甲基取代的吡喃衍生物的制备方法 | |
| JPH11501007A (ja) | ラモトリジンの製造法 | |
| CN107879979B (zh) | 一种右美托咪定的制备方法 | |
| KR101316653B1 (ko) | 헤테로고리 화합물의 제조방법 | |
| JP7815213B2 (ja) | ベンジルアミン誘導体、その調製方法およびその用途 | |
| JP2022524741A5 (https=) | ||
| CN113387934B (zh) | 一种多芳基取代咪唑衍生物及其制备方法与应用 | |
| CN112851577A (zh) | 瑞戈非尼的制备方法 | |
| JP2022515696A (ja) | エフィナコナゾールの調製方法 | |
| CN106674144B (zh) | 一种神经外科药物替马西泮中间体化合物的合成方法 |